Agenus News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.05.24	Ligand Enters Into $100 Mln Royalty Financing Agreement With Agenus For BOT/BAL Clinical Dvpt. (RTTNews)
12.04.24	Agenus Stock Falls After Reporting Updated Phase 1 Data On Colorectal Cancer Therapy (RTTNews)
12.04.24	Agenus Updates Phase 1 Data Of BOT/BAL Therapy In MSS Metastatic Colorectal Cancer (RTTNews)
22.01.24	Agenus' Botensilimab Study Shows Unprecedented Tumor Shrinkage (RTTNews)
11.12.23	Agenus To Receive Milestone Payment From Bristol Myers Squibb - Quick Facts (RTTNews)
08.08.23	Agenus Inc. Q2 Earnings Summary (RTTNews)
17.04.23	Agenus: FDA Grants Fast Track Designation For Botensilimab And Balstilimab In Colorectal Cancer (RTTNews)
24.08.21	Investors Cheer As Agenus Chugs Along (RTTNews)
18.05.21	Agenus Grants Bristol Myers Squibb License To Bispecific Antibody Program, AGEN1777 - Quick Facts (RTTNews)
11.09.20	AVXL On Watch, STSA Reels With Pain As Migraine Study Fails, HSTO To Report Alopecia Data In Q4 (RTTNews)
03.06.20	AGEN, AGE To Battle Coronavirus, BCLI Awaits ALS Trial Data, FDA Delays Decision On NVS' Drug (RTTNews)
18.01.19	6 Top Gainers In Healthcare Sector (BIOC, AGEN, LPCN...) (RTTNews)
21.12.18	AGEN Soars On GILD Deal, FENC Rolling Ahead, AIMT Gaining Steam (RTTNews)
20.12.18	Agenus Collaborates With Gilead On Immuno-Oncology Therapies; Stock Surges (RTTNews)
22.08.18	CVM Gearing Up For Big Event, BLFS Full Of Life, CRON Abuzz, AXON Awaits Data (RTTNews)
20.06.18	Agenus to Webcast Annual Meeting of Stockholders (PR Newswire)
12.06.18	Agenus Discovery Enhances Activity of Cancer Fighting Antibodies; Findings Published in Cancer Cell (PR Newswire)
06.06.18	Agenus to Present at the Jefferies 2018 Global Healthcare Conference in New York, NY (PR Newswire)
04.06.18	Agenus Presents Clinical Responses of AGEN1884 (anti-CTLA-4) and AGEN2034 (anti-PD-1) at ASCO 2018 (PR Newswire)
17.05.18	Agenus to Present Clinical Data on Lead Programs at ASCO 2018 (PR Newswire)
07.05.18	Agenus to Present at Deutsche Bank's 43rd Annual Health Care Conference in Boston (PR Newswire)
07.05.18	Agenus Reports First Quarter 2018 Financial Results and Provides Corporate Update (PR Newswire)
03.05.18	Agenus to Report First Quarter 2018 Financial Results on May 7, 2018 and Host Conference Call and Webcast (PR Newswire)
01.05.18	AgenTus Therapeutics to Present on Novel TCR Platform and Progress at PEGS Summit in Boston, MA (PR Newswire)
11.04.18	Three Agenus Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) 2018 Annual Meeting (PR Newswire)
29.03.18	Agenus to Present at Healthcare Investor Conferences In April (PR Newswire)
15.03.18	Agenus Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update (PR Newswire)
07.03.18	Agenus to Report Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018 and Host Conference Call and Webcast (PR Newswire)
22.01.18	Agenus Announces Combination Clinical Trials of its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034) (PR Newswire)
22.01.18	Agenus Inc. Closes $230 Million Royalty Monetization with HealthCare Royalty Partners (PR Newswire)
08.01.18	Agenus Inc. Announces $230 Million Royalty Monetization with HealthCare Royalty Partners (PR Newswire)
04.01.18	Agenus' Dr. John Castle Joins Thought Leadership Panel on I-O Combinations at 10th Annual Biotech Showcase 2018 (PR Newswire)
03.01.18	Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings (PR Newswire)
15.11.17	Agenus Receives License Fee of $4 Million USD from Merck (PR Newswire)
09.11.17	Agenus To Present on Lead Antibody Programs AGEN1884 (CTLA-4) and AGEN2034 (PD-1) at SITC 2017 (PR Newswire)
08.11.17	Agenus to Present at the Jefferies Global Healthcare Conference in London (PR Newswire)
07.11.17	Agenus Reports Third Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
26.10.17	Agenus to Report Third Quarter 2017 Financial Results on November 7, 2017 and Host Conference Call and Webcast (PR Newswire)
26.10.17	It's A No For PTCT As Expected, SRPT Revises Outlook Higher, TSRO Gets FDA Nod (RTTNews)
25.10.17	Shingrix with QS-21 Stimulon® Receives Positive Recommendation from CDC's Advisory Committee on Immunization Practices as Preferred Vaccine for Prevention of Shingles (PR Newswire)
23.10.17	Bruno Lucidi Appointed Chief Executive Officer of AgenTus Therapeutics, The Cell Therapy Subsidiary of Agenus (PR Newswire)
23.10.17	Agenus creates New Cell Therapy subsidiary named AgenTus Therapeutics (PR Newswire)
21.10.17	FDA Approves GSK's Shingles Vaccine with Agenus' QS-21 Stimulon® Adjuvant (PR Newswire)
13.10.17	GSK's Shingrix Containing Agenus' QS-21 Stimulon® Adjuvant Receives Marketing Authorization from Health Canada (PR Newswire)
19.09.17	Agenus to Present at Two Healthcare Investor Conferences In September (PR Newswire)
13.09.17	GSK's Shingrix containing Agenus' QS-21 Stimulon® adjuvant receives Unanimous FDA Advisory Committee recommendation for approval (PR Newswire)
13.09.17	FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over (PR Newswire)
12.09.17	Biotech Stocks on Investors' Radar -- PDL BioPharma, Progenics Pharma, Agenus, and Aptose Biosciences (PR Newswire)
04.08.17	How These Biotech Stocks are Performing? -- Agenus, Aptose Biosciences, RXi Pharma, and Tenax Therapeutics (PR Newswire)
03.08.17	Agenus Reports Second Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

10.04.24		Mittwochshandel in New York: NASDAQ Composite liegt zum Ende des Mittwochshandels im Minus
10.04.24		Mittwochshandel in New York: NASDAQ Composite fällt mittags zurück
09.04.24		Pluszeichen in New York: NASDAQ Composite verbucht zum Handelsstart Zuschläge
08.04.24		Börse New York in Grün: NASDAQ Composite verbucht zum Handelsende Zuschläge
08.04.24		Starker Wochentag in New York: Am Nachmittag Gewinne im NASDAQ Composite
08.04.24		Freundlicher Handel in New York: NASDAQ Composite am Montagmittag mit Gewinnen
08.04.24		Börse New York: NASDAQ Composite steigt zum Start
05.04.24		Freitagshandel in New York: NASDAQ Composite beginnt Handel in der Gewinnzone

10.04.24

Mittwochshandel in New York: NASDAQ Composite liegt zum Ende des Mittwochshandels im Minus

10.04.24

Mittwochshandel in New York: NASDAQ Composite fällt mittags zurück

09.04.24

Pluszeichen in New York: NASDAQ Composite verbucht zum Handelsstart Zuschläge

08.04.24

Börse New York in Grün: NASDAQ Composite verbucht zum Handelsende Zuschläge

08.04.24

Starker Wochentag in New York: Am Nachmittag Gewinne im NASDAQ Composite

08.04.24

Freundlicher Handel in New York: NASDAQ Composite am Montagmittag mit Gewinnen

08.04.24

Börse New York: NASDAQ Composite steigt zum Start

05.04.24

Freitagshandel in New York: NASDAQ Composite beginnt Handel in der Gewinnzone

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.65	2.61 %	K V
Lonza Grp	528.00	1.27 %	K V
Logitech Intl	71.64	0.87 %	K V
Part Grp Hldg	1’274.50	0.87 %	K V
UBS Group	28.53	0.81 %	K V
Givaudan	3’927.00	-0.15 %	K V
Swisscom	508.00	-0.29 %	K V
Zurich Insur Gr	550.20	-0.51 %	K V
Swiss Life Hldg	729.60	-0.55 %	K V
Novartis	92.90	-0.83 %	K V

Nachrichten zu Agenus Inc

Aktien Top/Flop

Agenus Peer Group Nachrichten

Meistgelesene Nachrichten